Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Salicylic Acid Dermo-Cosmetic with Epiduo for Acne
NCT03832647Phase 4Completed
- Sponsor
- L'Oréal
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Salvax in acne vulgaris (2 arms), sponsored by L'Oréal. Primary endpoint: Evaluation of the anti-acne efficacy 1 (number of the retentional and inflammatory lesions) at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
Salvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03832647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03832647.